Super DC Vaccine by Shanghai Cell Therapy Group for Solid Tumor: Likelihood of Approval
Pharmaceutical Technology
OCTOBER 3, 2023
Super DC Vaccine is under clinical development by Shanghai Cell Therapy Group and currently in Phase I for Solid Tumor.
Let's personalize your content